This inventor holds 1 USPTO granted patent. Top assignee: Monash University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Enyuan Cao: Innovator in Metabolic Disease Treatment
Introduction
Enyuan Cao is a prominent inventor based in Clayton, Australia. He has made significant contributions to the field of metabolic disease treatment, particularly focusing on obesity, insulin resistance, and type 2 diabetes. His innovative approaches have the potential to improve the lives of many individuals suffering from these conditions.
Latest Patents
Enyuan Cao holds 1 patent for his invention titled "Methods and compounds for treatment of metabolic disease." This patent provides methods for treating metabolic diseases using inhibitors of COX-2 or VEGFR and lipid prodrugs of COX-2 inhibitors, specifically celecoxib lipid prodrugs. These methods promote the transport of the pharmaceutical agent to the lymphatic system and enhance the release of the parent agent.
Career Highlights
Enyuan Cao is affiliated with Monash University, where he conducts research and develops innovative solutions for metabolic diseases. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Enyuan collaborates with various professionals in his field, including his coworker Natalie Trevaskis. Their combined expertise contributes to the development of effective treatments for metabolic diseases.
Conclusion
Enyuan Cao's work in the treatment of metabolic diseases showcases his dedication to innovation and improving healthcare. His contributions are vital in the ongoing fight against conditions like obesity and diabetes.